Your browser doesn't support javascript.
loading
A practical guide to estimating treatment effects in patients with rheumatic diseases using real-world data.
Pripp, Are Hugo; Losinska, Katarzyna; Korkosz, Mariusz; Haugeberg, Glenn.
Afiliación
  • Pripp AH; Oslo Centre of Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway. apripp@ous-hf.no.
  • Losinska K; Faculty of Health Science, OsloMet - Oslo Metropolitan University, Oslo, Norway. apripp@ous-hf.no.
  • Korkosz M; Division of Rheumatology and Immunology, University Hospital, Krakow, Poland.
  • Haugeberg G; Division of Rheumatology, Department of Internal Medicine, Sørlandet Hospital, Kristiansand, Norway.
Rheumatol Int ; 44(7): 1265-1274, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38656609
ABSTRACT

OBJECTIVE:

Randomized controlled trials are considered the gold standard in study methodology. However, due to their study design and inclusion criteria, these studies may not capture the heterogeneity of real-world patient populations. In contrast, the lack of randomization and the presence of both measured and unmeasured confounding factors could bias the estimated treatment effect when using observational data. While causal inference methods allow for the estimation of treatment effects, their mathematical complexity may hinder their application in clinical research.

METHODS:

We present a practical, nontechnical guide using a common statistical package (Stata) and a motivational simulated dataset that mirrors real-world observational data from patients with rheumatic diseases. We demonstrate regression analysis, regression adjustment, inverse-probability weighting, propensity score (PS) matching and two robust estimation methods.

RESULTS:

Although the methods applied to control for confounding factors produced similar results, the commonly used one-to-one PS matching method could yield biased results if not thoroughly assessed.

CONCLUSION:

The guide we propose aims to facilitate the use of readily available methods in a common statistical package. It may contribute to robust and transparent epidemiological and statistical methods, thereby enhancing effectiveness research using observational data in rheumatology.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Reumáticas Límite: Humans Idioma: En Revista: Rheumatol Int Año: 2024 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Reumáticas Límite: Humans Idioma: En Revista: Rheumatol Int Año: 2024 Tipo del documento: Article País de afiliación: Noruega